Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6XRL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $32,500
Award facts
- Contract value 100% obligated
- $32,499.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 on August 25, 2025, for the supply of Stelara 90 mg/mL syringes. The contract, which carries no set-aside designation, is scheduled for completion by September 16, 2025, and will be performed at the vendor's Park Ridge facility. This delivery order is funded through the Defense Logistics Agency's Medical Supply Chain division under the SPE2DB Indefinite Delivery Contract program, a $499.999 billion vehicle that enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare systems worldwide.
This award represents one of numerous delivery orders issued to DMS Pharmaceutical Group under its existing DLA indefinite delivery contract, which remains valid through November 2026. Stelara is a biologic immunosuppressant medication, and this delivery represents the company's continued role as a critical supplier of specialty pharmaceutical products to military healthcare facilities. The company has established a robust track record delivering branded and generic prescription drugs, biologics, and medical consumables, including oncology treatments, vaccines, and specialized medications, positioning it as a key participant in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DX25F6XRL?
SPE2DX25F6XRL was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 25, 2025.
How much is contract SPE2DX25F6XRL worth?
The government has obligated $32,500 on SPE2DX25F6XRL.
Is contract SPE2DX25F6XRL an order under another contract?
Yes. SPE2DX25F6XRL is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XRL competed?
The extent of competition for SPE2DX25F6XRL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award